| Updated:
Reckitt Benckiser to be sued for £89m over supply of Gaviscon
THE health authorities are suing Reckitt Benckiser for £89m over the supply of its heartburn medicine Gaviscon, the company said yesterday.
“We will be vigorously defending it [the lawsuit],” a Reckitt spokeswoman said.
In October, Reckitt was fined £10.2m by the Office of Fair Trading after admitting abuse of its dominant position in Britain for the supply of Gaviscon.
Reckitt admitted infringing British and European competition law by withdrawing and delisting Gaviscon Liquid original from the NHS prescription service in 2005 and replacing it with a different-formula Gaviscon Liquid advance, for which there is no generic rival.